Loading…
ProKidney Corp. is projected to rise to $2.00 by 2027, a +11% move from its current price of $1.81. PROK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.75 | $1.81 | $1.87 | +0.03% |
| May 30 | $1.72 | $1.81 | $1.90 | +0.05% |
| May 31 | $1.71 | $1.81 | $1.92 | +0.08% |
| Jun 1 | $1.69 | $1.81 | $1.94 | +0.11% |
| Jun 2 | $1.68 | $1.81 | $1.96 | +0.13% |
| Jun 3 | $1.67 | $1.81 | $1.97 | +0.16% |
| Jun 4 | $1.65 | $1.81 | $1.99 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.65 | $1.81 | $1.99 | +0.19% |
| Week 2 | $1.60 | $1.82 | $2.07 | +0.38% |
| Week 3 | $1.55 | $1.82 | $2.13 | +0.57% |
| Week 4 | $1.52 | $1.82 | $2.19 | +0.75% |
| Week 5 | $1.49 | $1.83 | $2.24 | +0.94% |
| Week 6 | $1.46 | $1.83 | $2.29 | +1.13% |
| Week 7 | $1.44 | $1.83 | $2.34 | +1.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ProKidney Corp. is a clinical-stage biotechnology company that develops cell therapies for the treatment of chronic kidney diseases in the United States. It develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes.
The pipeline also includes cryopreserved versions of rilparencel, REGEN-006 and REGEN-008, both in Phase III, as well as REGEN-002, REGEN-003, and REGEN-007 in Phase II, and REGEN-004 in Phase I. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
ProKidney Corp trades in the Healthcare sector. The stock is currently priced at $1.75 per share, with a market capitalization of $528.6M and a market rank of 3003. The long-range forecast projects a path of gradual potential upside, with the 2026 average price at $1.75 and a 2050 average price of $5.08, along with a 2050 maximum of $10.10 and a 2050 ROI of 190.4%.
A major floor 32.8% below — a decisive break under it would weaken the trend.
The nearest floor, 14.4% below — buyers have tended to step in here.
The nearest ceiling, 20.4% above — a clean break opens room to run.
A major ceiling 37.0% above — clearing it would confirm fresh momentum.
Key PROK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PROK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.74 | Buy | $1.74 | Buy |
| MA 10 | $1.70 | Buy | $1.74 | Buy |
| MA 20 | $1.78 | Buy | $1.78 | Buy |
| MA 50 | $1.86 | Sell | $1.88 | Sell |
| MA 100 | $2.02 | Sell | $2.00 | Sell |
| MA 200 | $2.29 | Sell | $2.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.42 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 19.45 | Neutral |
| Williams %R (14) | -21.21 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -2.69 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 78.79 | Neutral |
| TRIX (15) | -0.49 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 55.49 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.78 | Buy |
| ADX (14) | 15.17 | Neutral |
| ATR (14) | 0.06 | Info |
In the near term, sentiment is BEARISH. The RSI(14) is 50, and the 50-day simple moving average is $1.88 while the 200-day simple moving average is $2.30. Support is at $1.55 and resistance at $2.18. Over the last 30 days, the price has traded in a range of $1.41 to $2.17.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.55 | $1.81 | $2.43 | 0% | Neutral | |
| $1.55 | $2.00 | $2.77 | +11% | Neutral | |
| $1.50 | $2.01 | $2.90 | +11% | Neutral | |
| $1.30 | $1.80 | $2.69 | -1% | Neutral | |
| $1.35 | $1.92 | $2.95 | +6% | Neutral | |
| $1.46 | $2.13 | $3.36 | +18% | Neutral | |
| $1.64 | $2.44 | $3.93 | +35% | Bullish | |
| $1.83 | $2.78 | $4.58 | +54% | Bullish | |
| $1.69 | $2.62 | $4.40 | +45% | Bullish | |
| $1.66 | $2.63 | $4.49 | +45% | Bullish | |
| $2.16 | $3.76 | $6.89 | +108% | Bullish | |
| $2.65 | $5.45 | $11.09 | +201% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.55 | $1.81 | $2.14 | +0.00% |
| June 2026 | $1.60 | $1.89 | $2.29 | +4.37% |
| July 2026 | $1.55 | $1.85 | $2.29 | -1.81% |
| August 2026 | $1.51 | $1.82 | $2.27 | -2.12% |
| September 2026 | $1.54 | $1.86 | $2.36 | +2.70% |
| October 2026 | $1.54 | $1.88 | $2.40 | +1.00% |
| November 2026 | $1.50 | $1.84 | $2.37 | -2.35% |
| December 2026 | $1.52 | $1.88 | $2.43 | +2.11% |
Click any year to see its month-by-month PROK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PROK is projected to trade between $1.55 and $2.43, averaging $1.81 — a potential gain of 0% from today's $1.81. A consolidation phase looks the most probable path here.
ProKidney Corp.'s 2027 outlook centres on $2.00, within a $1.55 to $2.77 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, PROK could reach as high as $2.90, with a base case around $2.01 and support toward $1.50 — roughly +11% from $1.81. A consolidation phase looks the most probable path here.
Expect PROK to range from $1.30 to $2.69 through 2029. The $1.80 average target implies a -1% move from current prices. That is -11% versus the projected 2028 average. Price action looks broadly range-bound.
The PROK price prediction for 2030 points to an average of $1.92 (low $1.35, high $2.95) — a potential gain of +6% on today's $1.81. A consolidation phase looks the most probable path here.
In 2031, PROK is projected to trade between $1.46 and $3.36, averaging $2.13 — a potential gain of +18% from today's $1.81. That is up +11% on the projected 2030 average. Price action looks broadly range-bound.
ProKidney Corp.'s 2032 outlook centres on $2.44, within a $1.64 to $3.93 range. That is up +14% on the projected 2031 average. That marks a +35% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PROK could reach as high as $4.58, with a base case around $2.78 and support toward $1.83 — roughly +54% from $1.81. Momentum favours further upside here.
Expect PROK to range from $1.69 to $4.40 through 2034. The $2.62 average target implies a +45% move from current prices. That is -6% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The PROK price prediction for 2035 points to an average of $2.63 (low $1.66, high $4.49) — a potential gain of +45% on today's $1.81. Momentum favours further upside here.
In 2040, PROK is projected to trade between $2.16 and $6.89, averaging $3.76 — a potential gain of +108% from today's $1.81. That is up +43% on the projected 2035 average. Buyers look set to stay in control over this stretch.
ProKidney Corp.'s 2050 outlook centres on $5.45, within a $2.65 to $11.09 range. That is up +45% on the projected 2040 average. That marks a +201% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PROK today (≈ 552.486188 PROK) could be worth
$3,008.42
+$2,008.42 (+201%) by 2050 · US Dollar
Based on the average projected PROK price of $5.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PROKwould be worth at today's price.
$1,000 invested in PROK on May 27, 2025 (≈ 1,369.862978 PROK) would be worth
$2,479.45
+$1,479.45 (+147.9%) today · 2.48× · US Dollar
Based on a PROK entry price of $0.73 vs. today's $1.81.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.69 | $1,071.01 | +7.1% |
| 1 month ago | $1.86 | $973.12 | -2.7% |
| 3 months ago | $2.23 | $811.66 | -18.8% |
| 6 months ago | $2.22 | $815.32 | -18.5% |
| 1 year ago | $0.73 | $2,479.45 | +147.9% |
| All time (4.9y) ago | $10.11 | $179.03 | -82.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PROK forecast.
Our base-case forecast reaches $3.60 around 2040.
Implied market cap at $3.60: $738.72M
The year-by-year forecast shows a shift from neutral to bullish sentiment starting in 2032, with notable upside thereafter. For 2032 the min is $1.56, the avg is $2.29, the max is $3.63, and the ROI is 30.6% with a BULLISH outlook. In 2033 the min is $1.73, the avg is $2.59, the max is $4.20, ROI 48% and a BULLISH stance; 2034 min $1.61, avg $2.46, max $4.06, ROI 40.5%; 2035 min $1.60, avg $2.49, max $4.17, ROI 42% with bullish sentiment.
The forecast continues to rise toward 2040 with min $2.04, avg $3.45, max $6.21 and ROI 97.3% (BULLISH), and culminates in 2050 with min $2.58, avg $5.08, max $10.10 and ROI 190.4% (BULLISH). The values reflect potential upside across the coming years, balanced by inherent uncertainty and market volatility.
Tap a question to reveal the answer.
2030 forecast shows min $1.31, avg $1.83, max $2.79, with ROI 4.8% and sentiment NEUTRAL.
The forecast includes years with positive ROI (e.g., 2027 ROI 10.5%, 2032 ROI 30.6%, 2033 ROI 48%, 2040 ROI 97.3%, 2050 ROI 190.4%) and bullish sentiment in later years, but there are years with neutral or negative signals (e.g., 2029 ROI -0.4%). These are estimates, not guarantees.
Yes. The 2050 forecast shows an avg price of $5.08, with a max of $10.10 and ROI 190.4% under a BULLISH sentiment.
The 30-day range is $1.41 to $2.17.
Current price is $1.75 and market cap is $528.6M.
ProKidney Corp. Community Discussion
0Share your ProKidney Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.